My impression is they don't make much money on COVID related sales.
See page 5 from their FY20 presentation:
"Management replaced much of the elective surgery lost revenue with new income streams (e.g. PPE sales). However gross margins were lower during the final quarter. The Company’s gross margin for FY20 was still a respectable 37.5% (FY19 40.3%) nonetheless."
Shareholder Update, page-12
Add PGC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.8¢ |
Change
-0.003(0.53%) |
Mkt cap ! $786.2M | |||
| Open | High | Low | Value | Volume |
| 47.0¢ | 47.5¢ | 46.0¢ | $36.86K | 79.46K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 973 | 46.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.0¢ | 8884 | 4 |
View Market Depth
| Last trade - 12.44pm 21/10/2024 (20 minute delay) ? |
| PGC (ASX) Chart |